MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Characteristics of patients with essential tremor evaluated for deep brain stimulation surgery at a tertiary center

    L. Deuel, J. Feuerstein, B. Berman, B. Hoyt, D. Kern (Aurora, CO, USA)

    Objective: Characterize patients with essential tremor (ET) referred to a tertiary center for deep brain stimulation (DBS), including reasons for not proceeding with surgery. Background:…
  • 2019 International Congress

    Resting-State fMRI in Essential Tremor after MRgFUS treatment

    C. Kindler, V. Purrer, N. Upadhyay, V. Keil, V. Borger, C. Pieper, L. Scheef, H. Boecker, U. Wuellner (Bonn, Germany)

    Objective: Identify network alterations in essential tremor (ET) after magnetic resonance–guided focused ultrasound (MRgFUS) treatment using independent component analysis (ICA). Background: MRgFUS has been approved…
  • 2019 International Congress

    Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity

    L. Rocchi, A. Latorre, G. Paparella, E. Menozzi, L. Peppoloni, F. Valero-Cuevas, C. Cordivari, K. Bhatia, J. Rothwell (London, United Kingdom)

    Objective: To assess improvement in hand function following therapy with botulinum toxin in patients with dystonic tremor (DT). Background: Treatment of dystonic tremor (DT) with…
  • 2019 International Congress

    The mechanism of tremor-modulating properties of propranolol and primidone in essential tremor: A study with transcranial magnetic stimulation and eye blink classical conditioning paradigm

    K. Vogelnik, N. Prezelj, R. Perellon Alfonso, P. Klavžar, M. Gregorič Kramberger, D. Flisar, D. Georgiev, Z. Pirtošek, M. Kojović (Ljubljana, Slovenia)

    Objective: To explain central mechanisms of propranolol and primidone action and to study pathophysiology of essential tremor (ET). Background: Neurophysiological studies suggest that both motor…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    The legacy of Charles David Marsden: A role model in the field of movement disorders

    G. Froehner, L. Zubko, M. Pedro Franco, A. Meira, F. Germinani, H. Teive (Curitiba, Brazil)

    Objective: The report provides material about David Marsden's life and achievements in Neurology and specially in Movement Disorders field. Background: Marsden obtained his Master’s degree…
  • 2019 International Congress

    Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

    R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Almeida, AG. Velon (Vila Real, Portugal)

    Objective: Compare motor and non-motor symptoms between VP and PD patients. Background: VP is usually described as “lower-body parkinsonism”, with early gait difficulties and postural…
  • 2019 International Congress

    Clinical-instrumental algorithm for assessment visuospatial dysfunction in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study the features of visual spatial dysfunction (VSD) in patients with Parkinson's disease (PD) using modern clinical-neuropsychological, ophthalmological and neuroimaging methods. Background: Visual…
  • 2019 International Congress

    Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

    D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To identify cut-off points on the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS) for non-motor symptoms (NMS) burden grading. Background: NMS burden…
  • 2019 International Congress

    Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

    E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)

    Objective: Compare the ON and OFF cognitive performance of patients with PD receiving Subthalamic nucleus Deep Brain Stimulation (STN-DBS) using a computerized neuropsycological battery called…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley